But that's not the official word on the phased development. Immunex spokeswoman Cathy Keck Anderson says the company "has not announced the scope of the project we are building at this time, or the completion date." Those details and others will be announced at the ground-breaking to be held at the site Jan. 23.

Terminal 88 and Pier 89 form a peninsula, which is separated from Lower Queen Anne by extensive railroad tracks. Until now, the site has been land-locked. However, as an inducement to build, the City and Port of Seattle are building a new Interstate 5 off ramp, which will carry traffic over the tracks to the Immunex campus. The reported cost for the access project is between $15 million and $19 million.

Immunex pieced together its 29-acres through a number of purchases. In one acquisition this past fall, the company acquired 6.4 of acres from Colorado investor and developer Chuck Walthen for a reported $20.3 million. A partnership of Walthen's had purchased the property less than six months earlier for a mere $12.25 million, according to King County property records. Also in the third quarter, Immunex purchased 1.9 acres from Seattle Filmworks for $7.25 million.

The operations of Seattle-based Immunex are currently housed in six buildings in downtown Seattle, including 51 University St. and 1000 Second Ave. Anderson tells GlobeSt the new Research and Technology Center will unite all of those operations. The total square footage Immunex will be returning to the market as a result of the relocations was not immediately available.

Founded in 1981, Immunex develops biopharmaceutical products to treat cancer, autoimmune disorders, and infectious diseases. It also is developing drugs to treat asthma, leukemia, and osteoporosis. Pharmaceutical giant American Home Products owns about 40% of Immunex.

Want to continue reading?
Become a Free ALM Digital Reader.

Once you are an ALM Digital Member, you’ll receive:

  • Breaking commercial real estate news and analysis, on-site and via our newsletters and custom alerts
  • Educational webcasts, white papers, and ebooks from industry thought leaders
  • Critical coverage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.